Geode Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.96M Buy
2,676,476
+20,976
+0.8% +$15.3K ﹤0.01% 3152
2025
Q1
$2.14M Buy
2,655,500
+55,861
+2% +$45.1K ﹤0.01% 3008
2024
Q4
$3.59M Buy
2,599,639
+34,494
+1% +$47.6K ﹤0.01% 2905
2024
Q3
$2.67M Buy
2,565,145
+182,914
+8% +$190K ﹤0.01% 3037
2024
Q2
$4.12M Buy
2,382,231
+178,537
+8% +$309K ﹤0.01% 2838
2024
Q1
$5.27M Buy
2,203,694
+122,093
+6% +$292K ﹤0.01% 2671
2023
Q4
$6.93M Buy
2,081,601
+136,634
+7% +$455K ﹤0.01% 2536
2023
Q3
$7.28M Buy
1,944,967
+524,359
+37% +$1.96M ﹤0.01% 2447
2023
Q2
$6.07M Buy
1,420,608
+112,238
+9% +$479K ﹤0.01% 2582
2023
Q1
$8.95M Buy
1,308,370
+47,950
+4% +$328K ﹤0.01% 2323
2022
Q4
$9.98M Buy
1,260,420
+31,211
+3% +$247K ﹤0.01% 2268
2022
Q3
$11.8M Buy
1,229,209
+32,357
+3% +$311K ﹤0.01% 2113
2022
Q2
$8.67M Buy
1,196,852
+28,796
+2% +$208K ﹤0.01% 2354
2022
Q1
$15.1M Sell
1,168,056
-26,704
-2% -$345K ﹤0.01% 2074
2021
Q4
$19.1M Sell
1,194,760
-3,024
-0.3% -$48.3K ﹤0.01% 1990
2021
Q3
$19.2M Buy
1,197,784
+14,216
+1% +$228K ﹤0.01% 1983
2021
Q2
$16.4M Buy
1,183,568
+84,257
+8% +$1.17M ﹤0.01% 2108
2021
Q1
$16.1M Buy
1,099,311
+111,841
+11% +$1.63M ﹤0.01% 2014
2020
Q4
$17.2M Buy
987,470
+29,410
+3% +$511K ﹤0.01% 1815
2020
Q3
$17.6M Buy
958,060
+3,101
+0.3% +$56.9K ﹤0.01% 1618
2020
Q2
$17.1M Sell
954,959
-14,023
-1% -$250K ﹤0.01% 1612
2020
Q1
$15.7M Buy
968,982
+74,836
+8% +$1.21M ﹤0.01% 1461
2019
Q4
$16.1M Buy
894,146
+37,577
+4% +$677K ﹤0.01% 1703
2019
Q3
$17.4M Buy
856,569
+65,606
+8% +$1.33M ﹤0.01% 1574
2019
Q2
$17.5M Buy
790,963
+93,978
+13% +$2.08M ﹤0.01% 1572
2019
Q1
$9.51M Buy
696,985
+66,510
+11% +$907K ﹤0.01% 1929
2018
Q4
$5.71M Sell
630,475
-5,339
-0.8% -$48.3K ﹤0.01% 2140
2018
Q3
$10.5M Buy
635,814
+128,389
+25% +$2.12M ﹤0.01% 1888
2018
Q2
$7.1M Buy
507,425
+71,097
+16% +$995K ﹤0.01% 2111
2018
Q1
$4.82M Buy
436,328
+47,315
+12% +$523K ﹤0.01% 2258
2017
Q4
$3.42M Buy
389,013
+9,621
+3% +$84.7K ﹤0.01% 2448
2017
Q3
$5.06M Buy
379,392
+56,266
+17% +$751K ﹤0.01% 2199
2017
Q2
$4.64M Buy
323,126
+50,377
+18% +$723K ﹤0.01% 2193
2017
Q1
$5.77M Buy
272,749
+34,139
+14% +$722K ﹤0.01% 2005
2016
Q4
$6.72M Buy
238,610
+22,449
+10% +$632K ﹤0.01% 1861
2016
Q3
$5.79M Buy
216,161
+10,696
+5% +$286K ﹤0.01% 1876
2016
Q2
$3.47M Buy
205,465
+103,752
+102% +$1.75M ﹤0.01% 2134
2016
Q1
$2.16K Buy
101,713
+8,935
+10% +$190 ﹤0.01% 2403
2015
Q4
$2.13M Buy
92,778
+3,291
+4% +$75.6K ﹤0.01% 2434
2015
Q3
$1.79M Buy
89,487
+2,871
+3% +$57.5K ﹤0.01% 2515
2015
Q2
$2.5M Buy
86,616
+25,023
+41% +$723K ﹤0.01% 2352
2015
Q1
$1.88M Buy
61,593
+24,466
+66% +$748K ﹤0.01% 2479
2014
Q4
$605K Buy
+37,127
New +$605K ﹤0.01% 3100